Insulinlike Growth Factor-1Ec (MGF) Expression in Eutopic and Ectopic Endometrium: Characterization of the MGF E-Peptide Actions In Vitro

The transcription of the insulinlike growth factor 1 (igf-1) gene generates three mRNA isoforms, namely IGF-1Ea, IGF-1Eb and IGF-1Ec (or MGF [mechano growth factor]). Herein, we analyzed the expression of IGF-1 isoforms in eutopic and ectopic endometrium (red lesions and endometriotic cysts) of women with endometriosis, and we characterized the actions of a synthetic MGF E-peptide on KLE cells. Our data documented that all three igf-1 gene transcripts are expressed in the stromal cells of the eutopic and ectopic endometrium; however, endometriotic cysts contained significantly lower IGF-1 isoform expression, both at the mRNA and protein level, as was shown using semiquantitative PCR and immunohistochemical methods. In addition, the glandular cells of the eutopic endometrium did not express any of the IGF-1 isoforms; however, the glandular cells of the ectopic endometrium (red lesions) did express the IGF-1Ec at mRNA and protein level. Furthermore, synthetic MGF E-peptide, which comprised the last 24 amino acids of the MGF, stimulated the growth of the KLE cells. Experimental silencing of the type 1 IGF receptor (IGF-1R) and insulin receptor expression of KLE cells (siRNA knock-out methods) did not alter the mitogenic action of the synthetic MGF E-peptide, revealing that MGF E-peptide stimulates the growth of KLE cells via an IGF-1R-independent and insulin receptor-independent mechanism. These data suggest that the IGF-1Ec transcript might generate, apart from mature IGF-1 peptide, another posttrans-lational bioactive product that may have an important role in endometriosis pathophysiology.

[1]  M. Koutsilieris,et al.  Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro. , 2009, In vivo.

[2]  Apostolos Papalois,et al.  IGF-1 Expression in Infarcted Myocardium and MGF E Peptide Actions in Rat Cardiomyocytes in Vitro , 2009, Molecular medicine.

[3]  K. Matthews,et al.  Mechano-growth factor reduces loss of cardiac function in acute myocardial infarction. , 2008, Heart, lung & circulation.

[4]  D. Leroith,et al.  The role of the IGF system in cancer growth and metastasis: overview and recent insights. , 2007, Endocrine reviews.

[5]  C. Pashos,et al.  The Economic Burden of Endometriosis , 2006 .

[6]  J. Cross,et al.  Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. , 2005, American journal of physiology. Endocrinology and metabolism.

[7]  N. Rosenthal,et al.  Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. , 2005, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[8]  C. S. Bickel,et al.  Time course of molecular responses of human skeletal muscle to acute bouts of resistance exercise , 2005, Journal of applied physiology.

[9]  J. Donnez,et al.  Typical and subtle atypical presentations of endometriosis , 2004, Obstetrics and gynecology clinics of North America.

[10]  Richard W. Orrell,et al.  Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise.[see comment] , 2003 .

[11]  R W Orrell,et al.  Expression of IGF‐I splice variants in young and old human skeletal muscle after high resistance exercise , 2003, The Journal of physiology.

[12]  Ya-Huei Kuo,et al.  Novel activities of pro-IGF-I E peptides: regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells. , 2002, Experimental cell research.

[13]  S. Kim,et al.  Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP-3 protease activity in the peritoneal fluid of patients with and without endometriosis. , 2000, Fertility and sterility.

[14]  C. Mitsiades,et al.  Insulin-like Growth Factor I and Urokinase-type Plasminogen Activator Bioregulation System as a Survival Mechanism of Prostate Cancer Cells in Osteoblastic Metastases: Development of Anti-Survival Factor Therapy for Hormone-Refractory Prostate Cancer , 2000, Molecular medicine.

[15]  W. Dmowski,et al.  Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. , 1998, Fertility and sterility.

[16]  M. Koutsilieris,et al.  Association of protease activity against IGFBP-3 with peritoneal fluid mitogens: possible implications for the ectopic growth of endometrial cells in women with endometriosis. , 1997, Anticancer research.

[17]  S. Chew,et al.  An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. , 1995, Endocrinology.

[18]  C T Roberts,et al.  Molecular and cellular aspects of the insulin-like growth factor I receptor. , 1995, Endocrine reviews.

[19]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[20]  M. Koutsilieris,et al.  Three‐dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  J. Siegfried,et al.  A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Koutsilieris,et al.  Pathophysiology of uterine leiomyomas. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[23]  M. Koutsilieris,et al.  Effects of human prostatic mitogens on rat bone cells and fibroblasts. , 1987, The Journal of endocrinology.

[24]  R. Noyes,et al.  Dating the endometrial biopsy. , 1950, American journal of obstetrics and gynecology.

[25]  Robert H. Bell,et al.  Insulin receptor expression by human prostate cancers , 2009, The Prostate.

[26]  M. Koutsilieris,et al.  Characterization of a rabbit antihuman mechano growth factor (MGF) polyclonal antibody against the last 24 amino acids of the E domain. , 2008, In vivo.

[27]  M. Koutsilieris,et al.  Glucocorticoid receptor function suppresses insulin-like growth factor 1 activity in human KLE endometrial-like cells. , 2004, In vivo.

[28]  C. Mitsiades,et al.  International Congress on Hormonal Steroids and Hormones and Cancer Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton , 2003 .

[29]  M. Koutsilieris,et al.  Increased Insulin-like Growth Factor 1 Activity Can Rescue KLE Endometrial-like Cells from Apoptosis , 2001, Molecular medicine.

[30]  R. Gilmour,et al.  The implications of insulin-like growth factor mRNA heterogeneity. , 1994, The Journal of endocrinology.

[31]  S. Kornfeld.  Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. , 1992, Annual review of biochemistry.